
1、参会指南
大会时间
2025年8月27日-28日
大会地点
上海市静安区延安中路1218号上海静安香格里拉
主会场:上海静安香格里拉酒店,5楼
分会场:上海静安香格里拉酒店,3楼
签到地点
上海静安香格里拉五楼
签到时间
2025年8月27日(星期三) 09:00开始
2025年8月28日(星期四) 09:00开始
签到流程
本次大会需实名认证,所有参会人员均需线上报名。
1、扫描下方报名二维码填写报名信息(已提前报名的请略过此步骤);

2、现场签到台扫描签到码,领取参会证件。
交通指引
外部交通
上海火车站——驾车距离约4公里,时长15分钟左右;地铁1号线2号线至静安寺地铁站,时长25分钟左右
上海虹桥火车站——驾车距离约20公里,时长30分钟左右; 地铁2号线至南京西路地铁站,时长40分钟左右
上海虹桥国际机场——驾车距离约20公里,时长35分钟左右;地铁2号线至南京西路地铁站,时长40分钟左右
上海浦东国际机场——驾车距离约50公里,时长60分钟左右;地铁2号线至南京西路地铁站,时长1小时25分钟左右
市内交通
地铁2号线、7号线、14号线至静安寺地铁站8号口出,步行约700米
停车事宜
本次活动不提供停车券,请您自行安排
在酒店入住的客人可至三楼宴会厅服务人员处登记领取
会议用餐
时间:8月27日 12:00-13:30、地点:酒店三楼夏宫
时间:8月28日 12:00-13:30、地点:静安香格里拉酒店一楼:两咖啡餐厅
*仅限演讲嘉宾及VIP观众凭证件入场,普通观众及其他参会人员请自行解决用餐
会场指引
8月27日
|
时段 |
日程 |
地点 |
|
9:00-9:30 |
大会注册签到 |
5F宴会厅序厅 |
|
9:30-12:15 |
开幕式暨全体大会 |
5F大宴会厅 |
|
12:00-13:30 |
午餐会:东盟市场投融资需求对接(审核制) |
夏宫 |
|
13:30-17:05 |
ESG与新质生产力论坛 |
3F桂树厅 |
|
13:30-17:10 |
“智航四海,链启全球”出海分论坛 |
3F紫藤厅 |
|
13:30-17:15 |
新消费趋势展望论坛 |
3F白玉兰厅 |
|
13:30-16:50 |
中企全球化发展专业服务论坛 |
3F兰花厅 |
|
17:00-18:00 |
鸡尾酒会/晚宴签到 |
5F大宴会厅序厅+屋顶花园 |
|
18:18-21:00 |
沙利文全球GIL奖2025年度颁奖典礼暨客户答谢晚宴(邀请制) |
5F大宴会厅 |
8月28日
|
9:30-16:20 |
AI进化论-物理世界智能体系统构建论坛 |
3F白玉兰厅 |
|
13:30-17:55 |
上市公司高质量发展论坛(邀请制) |
3F兰花厅 |
|
9:30-17:25 |
生命科学新投资高峰论坛(平行会)——医药专场 |
3F桂树厅 |
|
9:30-17:15 |
生命科学新投资高峰论坛(平行会)——器械专场 |
3F紫藤厅 |
|
18:00-20:00 |
上市公司高质量发展专场晚宴(邀请制) |
3F白玉兰厅 |
-
会场平面图

参会须知
1、为保障您的权益,请在进出会场时随身佩戴证件,并在保安确认身份时配合展示。请各位与会嘉宾妥善保管,遗失不补。
2、会议期间请将手机铃声调成震动或静音,保持会场安静;未经允许,禁止对报告内容进行录音或录像;请自觉遵守场馆和会场内的各项规章制度。
关于如何获取免费WIFI,请遵循以下步骤:
-
在手机设置WIFI中,选择名称“Shangri-La”
-
手机会自动跳出登陆界面,非住店客人可以选择手机号码验证码登陆;或者选择点击微信验证登陆。
3、严禁在会议中心内外散发或摆放未经大会组委会允许的任何学术或产品资料。
2、大会日程
开幕式暨全体大会(8月27日)
|
9:30-9:35 |
主持人开场白 江予菲 上海电视台第一财经频道主持人 |
|
9:35-9:40 |
主办方全球董事局主席致欢迎辞 富大为 沙利文全球董事局主席 David Frigstad, Global Chairman, Frost & Sullivan |
|
9:40-9:50 |
主办方全球总裁致欢迎辞 祖亚儒 沙利文全球总裁兼主管合伙人 Aroop Zutshi, Global President & Managing Partner, Frost & Sullivan |
|
9:50-10:05 |
特邀贵宾主题演讲 屠光绍 上海新金融研究院理事长、上海交通大学上海高级金融学院创院理事长 |
|
10:05-10:10 |
贵宾致辞1 刘兆彬 国家质量监督检验检疫总局原总工程师、中国质量万里行促进会原会长 |
|
10:10-10:15 |
贵宾致辞2 张国华 中国广告协会会长、国际广告协会全球副主席 |
|
10:15-10:20 |
贵宾致辞3 王宇教授 中国肝炎防治基金会理事长 |
|
10:20-10:25 |
贵宾致辞4 孙念瑞 中国上市公司协会党委委员、副会长 |
|
10:25-10:30 |
贵宾致辞5 孔雪莉 徐州市产业发展基金管理有限公司董事长 |
|
10:30-10:35 |
贵宾致辞6 徐士龙 全国政协委员、世界发明创新联合会中方代表、江苏商会轮值会长、上海港湾集团 (605598.SH)董事长 |
|
10:35-10:40 |
贵宾致辞7 王廷富 兴富资本董事长 |
|
10:40-10:50 |
主题演讲 王昕博士 沙利文全球合伙人兼大中华区董事长 Dr. Neil Wang, Global Partner and Greater China Chairman, Frost & Sullivan |
|
10:50-11:00 |
2025沙利文新投资大会开幕启动仪式 |
|
11:00-11:05 |
研究报告”阳光行动” 启动仪式 |
|
11:05-11:15 |
沙利文全球专家顾问团聘任仪式 |
|
11:15-11:20 |
启动仪式 :大国品牌510发布:2025年度品牌无形资产增长榜单 发布人:王晨晖 沙利文大中华区主管合伙人兼总裁、头豹联合创始人兼总裁 尹杰《大国品牌》战略学者 张迪教授 中国人民大学国际新闻与传播系主任 |
|
11:20-11:30 |
发布仪式 :《2025年中国PE/VC基金行业CFO白皮书》、2025年中国PE/VC机构CFO榜单 发布人:杨晓骋 沙利文大中华区合伙人兼董事总经理 联合发布人:张威 ICS Group 基金总监 |
|
11:30-12:00 |
圆桌讨论:“新投资”大家谈 主持嘉宾:曹卉 中新社(北京)国际传播集团有限公司上海分公司总监 对话嘉宾:费建江 元禾原点管理合伙人 叶卫刚 达泰资本创始管理合伙人 王晓瑞 常见投资创始合伙人兼总经理 蔡丹枫 百联挚高资本创始合伙人 |
|
12:00-12:05 |
战略合作签约仪式 王晨晖 沙利文大中华区主管合伙人兼总裁 夏婷婷 香港《凤凰周刊》海外事业部总监 |
|
12:05-12:10 |
合作项目启动仪式 王晨晖 沙利文大中华区主管合伙人兼总裁 李梁 微博潮流与健康事业部总经理 |
|
12:10-12:15 |
主持人结束语 |
ESG与新质生产力论坛(8月27日)
|
13:30-13:35 |
主办方欢迎致辞 陆景 沙利文大中华区合伙人,董事总经理 |
|
13:35-14:00 |
主旨演讲1:当ESG遇到新质生产力,开启美丽的科创奇缘 汤哲辉 安永大中华区审计服务市场联席主管合伙人 |
|
14:00-14:25 |
主旨演讲2:锂电池企业全球化战略及ESG应对 刘佳 国轩高科行业研究部总经理 |
|
14:25-14:50 |
主旨演讲3:零碳智慧运输探索与实践 李满 质子汽车副总经理 |
|
14:50-15:15 |
主旨演讲4:新能源商用车如何拥抱全球冷链物流增长需求 陈剑锋 Singauto首席财务官 |
|
15:15-15:40 |
主旨演讲5:中国能源转型与发展新质生产力 朱亚明 安永大中华区能源与基础设施及碳中和主管合伙人 |
|
15:40-16:05 |
主旨演讲6:人工智能浪潮下:Agent产品商业化探索 周源 税友软件首席产品官 |
|
16:05-16:10 |
发布仪式1:全球ESG气候风险平台与报告行业的增长机遇白皮书 向威力 沙利文大中华区执行总监 |
|
16:10-16:15 |
发布仪式 2:2025中国ESG最佳企业实践报告、2025中国ESG最佳企业实践榜单 楼磊 沙利文大中华区执行总监 |
|
16:15-16:35 |
专家面对面 主持嘉宾:蔡宇帆 沙利文大中华区咨询经理 对话嘉宾:李菁 安永大中华区ESG可持续发展主管合伙人 |
|
16:35-17:00 |
圆桌讨论:新能源商用车企业的破局之道 主持嘉宾:李伊菲 沙利文大中华区高级咨询顾问 对话嘉宾:陈剑锋 Singauto首席财务官 李满 质子汽车副总经理 |
|
17:00-17:05 |
主持人总结与闭幕 |
“智航四海 链启全球”出海分论坛(8月27日)
|
13:32-13:35 |
主办方致辞 贾庞 沙利文大中华区合伙人及董事总经理 |
|
13:35-13:55 |
主旨演讲1:中国企业的品牌全球化以及如何在中东市场获得成功 Robin Joffe 沙利文合伙人兼中东、南亚、北非区总裁 Robin Joffe, Partner, Managing Director Middle East, South Asia, North Africa, Frost & Sullivan |
|
13:55-14:15 |
主旨演讲2:工业X射线检测装备的全球化布局 刘骏博士 日联科技董事长 |
|
14:15-14:35 |
主旨演讲3:东盟:世界第五大经济体与2025年及未来中国投资者面临的动态增长机遇 Hazmi Yusof 沙利文高级副总裁兼马来西亚负责人 Hazmi Yusof, SVP & Country Head - Malaysia, Frost & Sullivan |
|
14:35-14:55 |
主旨演讲4:瑞浦兰钧的出海之旅 吴艳军博士 瑞浦兰钧执行董事兼董事会秘书 |
|
14:55-14:15 |
主旨演讲5:日本新的消费趋势 Hiroshi Yamamura 沙利文日本总裁 Hiroshi Yamamura, Corporation County Head, Frost & Sullivan Japan |
|
14:15-15:35 |
主旨演讲6:新材料全球化突围之路 汪海明博士 凌凯科技首席科学家 |
|
15:35-15:40 |
发布仪式1:新型功能材料行业发展白皮书发布 谢书勤 沙利文大中华区执行总监 汪海明博士 凌凯科技首席科学家 |
|
15:40-16:00 |
主旨演讲7:高性能防腐材料的全球新篇章 杨志华 锌盾科技总经理 |
|
16:00-16:20 |
主旨演讲8:中企出海案例探究 杨淑娟 安永中国北京主管合伙人、安永大中华区政府及基础设施市场主管合伙人 |
|
16:20-17:05 |
圆桌论坛:企业出海的协同突围与生态共建 宋从越 安永华明会计师事务所(特殊普通合伙)上海分所审计业务合伙人 |
|
17:05-17:10 |
主持人结束语 |
中企全球化发展专业服务论坛(8月27日)
|
13:30-13:35 |
致辞 王晨晖 沙利文大中华区主管合伙人兼总裁 |
|
13:35-13:50 |
主旨演讲1:如何利用AI精准链接企业出海需求 赵亮 朗言数安数据安全专家、总经理 |
|
13:50-14:05 |
主旨演讲2:“出海”需关注的涉税风险 顾原睿 复旦大学国际金融学院税收研究中心联席主任 |
|
14:05-14:15 |
主旨演讲3:出海越南的Yes or No 严鹏飞 越南King Road创始人 |
|
14:15-14:45 |
主旨演讲4:科技出海 | 企业出海的三项修炼-组织、人才、跨文化 徐凤娇 快仓智能合伙人 |
|
14:45-15:00 |
茶歇 & 展区交流 |
|
15:00-15:30 |
主旨演讲5: 跨境出海 | 新周期下中国品牌出海机遇与挑战 贺伟林 海翼电商副总裁 |
|
15:30-15:45 |
主旨演讲6:从中国智造到全球品牌:中国芯品牌的大时代 崔洪波 正见品牌战略创始人兼首席执行官 |
|
15:45-16:45 |
Part 4 出海圆桌:群策出海共创 徐腾 追创创投合伙人 徐育浩 沙滩说基金投资总监 范长平 环世物流集团董事会秘书 周瑾 钛动战投负责人 刘大纲 嘉驰国际亚太区高级合伙人 |
新消费趋势展望论坛(8月27日)
|
13:30-13:33 |
主持人开场白 章晓菁 沙利文大中华区执行总监 |
|
13:33-13:35 |
主办方致辞 富大为 沙利文全球董事局主席 David Frigstad, Global Chairman, Frost & Sullivan |
|
13:35-13:45 |
致辞 刘旭 中国轻工业发展研究中心产业技术研究院副院长 |
|
13:45-14:05 |
主旨演讲1: 40年持续创新 铸就禹王全球营养品领军之路 刘锡潜 禹王集团董事长 |
|
14:05-14:25 |
主旨演讲2:食在中国-中国餐厅的创新 赵朋 广顺兴创始人 |
|
14:25-14:45 |
主旨演讲3:养生国潮-饮料行业的最新趋势 胡开基 椿风茶饮创始人 |
|
14:45-15:05 |
主旨演讲4:新消费趋势下的科学营销 徐苗 安永客户与增长服务合伙人 |
|
15:05-15:25 |
主旨演讲5:消费股IPO:解码香港上市窗口与二级市场定价逻辑 万勇 沙利文捷利云科技董事长、捷利交易宝首席行政官 |
|
15:25-15:45 |
主旨演讲6:掌控体验经济:赢在互动交流 Manoj Menon Twimbit创始人兼首席执行官 |
|
15:45-15:55 |
主旨演讲7:体育营销助力企业出海 胡晓苓 上海圆桌实业发展有限公司执行董事 |
|
15:55-16:05 |
主旨演讲8:AI新时代营销解决方案 袁栩聪 沙利文AI行业首席分析师、头豹研究院副院长 |
|
16:10-16:10 |
白皮书发布:《2025中国复合坚果行业发展白皮书》、《2025中国花生油行业白皮书》 沙利文大中华区执行总监 章晓菁 |
|
16:10-16:40 |
圆桌论坛1:烘焙供应链行业深入分析 主持嘉宾:张苏 新物种研究院院长 对话嘉宾:杨振 星巴克中国区CGO 苗苗 恒天然大中华区安佳专业乳品市场总监 李东 Tim Hortons中国区CFO 侯学铭 Olé精品超市烘焙中心负责人 陈耀雄 广州市六合食品有限公司创始人兼董事长 |
|
16:40-17:10 |
圆桌论坛2:健康食品新趋势 太白锦成 品跃大单品营销创始人 王乃鑫 可漾品牌总监 赵燕 路铁传媒企业合伙人&首席品牌官 |
|
17:10-17:15 |
主持人结束语 |
AI进化论-物理世界智能体系统构建论坛(8月28日)
|
9:00-9:30 |
签到 |
|
9:30-9:35 |
主持人开场白 张知为 沙利文大中华区执行总监 |
|
9:35-9:40 |
主办方致辞 杨晓骋 沙利文大中华区合伙人兼董事总经理 |
|
9:40-10:00 |
主题演讲1:2025年最具变革性的50大技术 Sae-Jun Park 沙利文韩国负责人 Sae-Jun Park, Associate Partner & Country Head, Frost & Sullivan Korea |
|
10:00-10:20 |
主题演讲2:港股AI行业IPO与再融资观察 万勇 沙利文捷利云科技董事长、捷利交易宝首席行政官 |
|
10:20-10:40 |
主题演讲3:新趋势、新变革:AI进入物理世界的趋势洞察 刘明瑞 安永战略与交易咨询合伙人 |
|
10:40-11:00 |
主题演讲4 刘骏博士 日联科技董事长 |
|
11:00-11:20 |
主题演讲5:人工智能驱动的产业转型 Ravi Krishnaswamy 沙利文亚太区董事总经理 Ravi Krishnaswamy, Managing Director, Asia Pacific, Frost & Sullivan |
|
11:20-11:40 |
主题演讲6:创新创业的结构性变革:AI的力量 房超 华中科技大学、清华大学教授,北京亦庄人工智能研究院、湖北光谷实验室首席战略科学家 |
|
11:40-11:50 |
白皮书发布:《2025年中国GenAI行业最佳应用实践》《2025年AI赋能千行百业洞察》 榜单发布:2025年中国AI Agent(智能体)最佳实践应用榜单 李庆 沙利文大中华区总监 |
|
11:50-13:30 |
午餐 |
|
13:30-13:35 |
主持人开场白 张知为 沙利文大中华区执行总监 |
|
13:35-13:55 |
主题演讲7:易普集致力推动AI数据中心遍在性 严昌平 易普集副总裁 |
|
13:55-14:15 |
主题演讲8:垂类大模型 从技术好用到产业可用的跃迁 喻友平 中关村科金总裁 |
|
14:15-14:35 |
主题演讲9:具身智能机器人的产业化探索与实践 万彬 擎朗COO |
|
14:35-14:55 |
主题演讲10:面向具身智能的数据合成 杨子江 深信科创创始人 |
|
14:55-15:15 |
主题演讲11:以 “数据燃料” 驱动未来:开悟世界模型为 AGI 开辟新航道 王飞 商汤绝影执行总监 |
|
15:15-15:35 |
主题演讲12:物理AI仿真系统,加速具身机器人商业化落地 聂凯旋 上海松应科技创始人CEO |
|
15:35-15:55 |
主题演讲13:AI 驱动下智能座舱的体验进化与场景创新 杨赖土 四维智联CEO |
|
15:55-16:15 |
主题演讲14:AI驱动下海外游客入境游数字化营销服务应用创新 郑雅静 汇智国际CFO |
|
16:15-16:20 |
主持人结束语 |
生命科学新投资高峰论坛平行会——医药专场(8月28日)
|
9:00-9:30 |
签到 |
|
9:30-9:35 |
主办方致辞 王晨晖 沙利文大中华区主管合伙人兼总裁 |
|
9:35-9:50 |
嘉宾致辞 王宇教授 中国肝炎防治基金会理事长 |
|
9:50-10:15 |
主题演讲1:医疗健康的未来:创新、投资与全球协作--激活中国潜能 Rhenu BhullerFrost & Sullivan Life Sciences and Digital Health Strategic Advisor Rhenu BhullerStrategic Advisor, Life Sciences & Digital Health, Frost & Sullivan |
|
10:15 - 10:40 |
Keynote 2: Breaking Boundaries in the International Market: Roche Pharmaceuticals and Innovative Collaboration with Chinese Pharmaceutical Companies He JianqiHead of R&D Asia for Roche Pharmaceuticals' China Business |
|
10:40 - 10:50 |
中场交流 |
|
10:50 - 11:15 |
Keynote 3: Continuous Iteration of Productivity in Biopharmaceutical Companies Xie XinExecutive Director and Senior Vice President of China Biopharmaceuticals |
|
11:15 - 12:25 |
Roundtable Discussion 1: Transcending Cycles: The Capital Lifecycle Management Approach for Biopharmaceutical Companies Host:WuyueVice General Manager of China International Financial Co., Ltd. Panelists:Li LihuaVP of R&D Management, Baiyang Medicine Group Cai XuejunChief Scientific Officer, Central Research Institute of Shanghai Pharmaceutical Group Liu YimingPartner-in-Chief, Shanghai Office of KLL Law Firm Wang HaijiaoPartner of GaoTEC Investment Group Wan YongChairman of SULLIVAN TELE-TREND CLOUD TECHNOLOGY, Chief Executive Officer of TradeGo & Frost & Sullivan Advisor |
|
12:25 - 13:20 |
Lunch |
|
13:20 - 13:45 |
Keynote 4:Analysis of the R&D Directions of Next-generation Small Molecule Drugs Sheng ZejuanVice President of Yaojie Ankang |
|
13:45 - 14:10 |
Lecture 5: Exploration and Practice of Mitochondrial Medicine in Longevity Medicine Lin ZirongExecutive Director of Kangnuo Biopharmaceutical Co., Ltd. |
|
14:10 - 14:15 |
Release Ceremony of the 'White Paper on the Current Situation and Development Trends of the Mitochondrial Medicine Industry in 2025' Zhang Chenyang Consulting Director, Healthcare Business Unit, Frost & Sullivan Greater China |
|
14:15 - 14:40 |
Keynote 6: Analysis of the Prospects for Next-Generation TCE Technologies Filial piety brings good fortuneChairman and CEO of Zhejiang Shimai Pharmaceutical Co., Ltd. |
|
14:40 - 14:50 |
tea break |
|
14:50 - 14:55 |
Blue Book on the Current Situation and Development Trends of Antibody Drugs Industry 2025 is Released Li QianExecutive Director, Healthcare Business Unit, Frost & Sullivan Greater China |
|
14:55 - 15:20 |
Keynote 7:RDC Industry Development and Opportunities: Current Status of Cu-64-labeled Radiopharmaceutical Development JinglanSenior Director of Enterprise Development, Tongrui Biopharmaceutical (Shanghai) Co., Ltd. |
|
15:20 - 15:45 |
Keynote 8: Cell Therapy Enters the Deep Waters of the Industry: Technological Upgrades and Commercialization Challenges Proceeding Hand in Hand Chen XingrongFosun Karry CEO |
|
15:45 - 16:10 |
Keynote 9: Automation and Intelligentization Trends in Life Science Laboratories under the AI Wave Zhang YanCo-founder and Senior Vice President of Magnesium Technology |
|
16:10 - 17:20 |
Roundtable Discussion 2: The Future Is Here, Innovation Breakthroughs and Accelerated Transformation of Advanced Therapies in China Host:Liu XiaolanManaging Director of Healthcare Industry Group of Investment Banking Committee at CITIC Securities Panelists:Zhou GuoyingFounder, Chairman and CEO of Yino Wei Medicine Wei JunCo-founder and CEO of Ruijian Medicine Jinhua JunCEO and CTO of Jun Sai Biology Wang Hongyuan CEO of Huali Lejian Ni DongyaoSenior Vice President, Xibimeng Biotechnology |
|
17:20 - 17:25 |
Host's Closing Remarks |
Parallel Session of the New Investment Summit Forum in Life Sciences - Medical Devices (August 28)
|
9:00 - 9:30 |
Sign-in |
|
9:30 - 9:35 |
Opening Remarks FatteningPartner and Managing Director of Frost & Sullivan Greater China Region |
|
9:35 - 9:50 |
Guest Speech Cai JiangnanFounder and Executive Chairman of Shanghai Chuangqi Health Development Research Institute |
|
9:50 - 10:15 |
Keynote 1: Analysis of New Trends in the Consumer Healthcare Ecosystem Cao LeDirector of Strategic Investment, Asia-Pacific Region, iQ TECH |
|
10:15 - 10:40 |
Keynote 2: Overseas Commercialization Practice of Minimally Invasive Surgical Robots —— Great Ambitions, Towards the Future Liu YuExecutive Director, Executive Vice President and Chief Commercial Officer of Shanghai MicroPort Medical Robotics (Group) Co., Ltd. |
|
10:40 - 10:50 |
Midfield communication |
|
10:50 - 11:15 |
Keynote 3: Analysis of New Investment Ideas in Medical Devices 2025 Sun XiaoluFounder and Managing Partner of Binlinxing Venture Capital |
|
11:15 - 12:15 |
Roundtable Discussion 1: Innovation-driven and Ecological Synergy: The Road to Breaking Through for the High-quality Development of Medical Devices in China Moderator:Cai LintingVice President, Healthcare Group, M&A Banking, Morgan Stanley Panelists:Cynthia ChenChairman of PAMU Medical Yang HeCEO of Weima Medical Zheng Hongzhe President of the Strategy Department, Jiangsu Yuyue Medical Equipment Co., Ltd. Xing ZhikaiDirector of Engineering Technology Center, Shanghai MicroPort Medical Technology (Group) Co., Ltd. Du PengBusiness Development Director of Shanghai Haohai Biotechnology Co., Ltd. |
|
12:15 - 13:20 |
Lunch |
|
13:20 - 13:45 |
Keynote 4Innovation and breakthroughs in innovative biomedical materials in the field of high-end medical implant devices Guo GuangxuChairman and CEO of Xi'an EyeMed Medical Technology Co., Ltd. |
|
13:45 - 14:10 |
Keynote 5:Development Trend of New Generation Cardiovascular Diagnostic and Therapeutic Devices Wang LiCEO & Chairman of Elixir Healthcare |
|
14:10 - 14:15 |
Release Ceremony of the "Blue Book on the Current Situation and Trends of Chinese Medical Devices Going Global in 2025" Hao ShuaiConsulting Director, Healthcare Business Unit, Frost & Sullivan Greater China |
|
14:15 - 14:40 |
Keynote 6:The Innovative Butterfly Transformation of Minimally Invasive Interventional Cryotherapy Zhu JunGeneral Manager & CEO of Kangfeng Biotechnology (Shanghai) Co., Ltd. |
|
14:40 - 14:50 |
tea break |
|
14:50 - 15:15 |
Keynote 7:Technological Innovation and Development of Recombinant Humanized Triple Helix Collagen and Its Medical Aesthetic Applications Zhang ChunliHengyi Biology CTO |
|
15:15 - 15:20 |
Release Ceremony of the "Blue Book on the Current Situation and Future Development of Medical Beauty Injection Products Industry in 2025" Zhao YidiConsulting Director, Healthcare Business Unit, Frost & Sullivan Greater China |
|
15:20 - 15:45 |
Keynote 8: Embracing Centralized Procurement - The Catalyst Effect in the New Procurement Landscape Ignites the Commercialization Engine ChehaiboChairman of CoreLogic Healthcare Technology |
|
15:45 - 16:10 |
Keynote 9: International Frontiers and Clinical Applications of Molecular Imaging Technology Chi ChongweiCEO of DPM |
|
16:10 - 17:10 |
Roundtable Discussion 2: From Followership to Leadership: The Road to Innovation and Market Reconfiguration in China's Medical Devices Moderator:Chen Qiqiang CITIC Construction Investment Securities Investment Banking Business Management Committee, Vice President Panelists:Liu MaiChairman of Yongxin Medical DinglinChief Financial Officer and Secretary of the Board of Directors of Aikex Medical Devices (Beijing) Co., Ltd. Ye YingHannover Medical Board Secretary ding ding dingHead of Northcore Life's Brand Communication and Investor Relations |
|
17:10 - 17:15 |
Host's Closing Remarks |
High-quality Development Forum for Listed Companies (August 28)
|
13:30 - 13:40 |
Host's opening remarks Theme: It's Time to Go Global!!! Wan YongChairman, TradeGo Chief Executive Officer & Frost & Sullivan of SULLIVAN TELE-TREND CLOUD TECHNOLOGY |
|
13:40 - 14:05 |
Keynote Speech 1: The Development Trend of M&A Reorganizations in Listed Companies under the Background of New Restructuring Regulations and Its Coping Strategies Professor Liu YunhongDeputy Director of the M&A Financing Committee of the China Listed Companies Association and Deputy Director of the International M&A and Investment Research Institute at Renmin University of China |
|
14:05 - 14:30 |
Keynote 2: The Path of Innovation and Internationalization at Dongguan Sunshine Pharma Dr. Youngjun ZhangChairman of Guangdong Dongguangyang Pharmaceutical Co., Ltd. and Dean of Dongguangyang Group Pharmaceutical Research Institute |
|
14:30 - 14:55 |
Keynote 3: The Machine Population Bonus in the Intelligent Era Zhi TaoFounder/Chairman of Yunji Technology |
|
14:55 - 15:25 |
Keynote 4: Seizing the Opportunity at RWA: The Financial Future That Listed Companies Cannot Ignore Wen HuijunPerson in charge of RWA Business Unit of Jinzhou Holdings |
|
15:25 - 15:50 |
tea break |
|
15:50 - 16:15 |
Keynote 5: Compliance-Driven and Effective Market Value Management of Hong Kong Listed Companies Yu ZhengGeneral Manager of TradeGo (Shanghai) |
|
16:15 - 16:40 |
Keynote Speech 6: Capital Operation Facilitates Strategic Transformation and Global Development of Listed Companies Zheng HongweiJunDA Co., Ltd. Director, Deputy General Manager |
|
16:40 - 17:05 |
Keynote 7: AI-Driven Innovation and Development in the Maternal and Infant Industry Zhang HongchenChief Product Officer of Different Groups and Co-founder of BeBeBus |
|
17:05 - 17:45 |
Roundtable Discussion: How the Capital Market Supports Companies' Overseas Expansion and Transformation and Upgrading Moderator:Wan YongChairman of SULLIVAN TELE-TREND CLOUD TECHNOLOGY, Chief Executive Officer of TradeGo & Frost & Sullivan Representative in China Joint Chair:He ZhaofengEY Hong Kong EMEA Listed Services Partner Dialogue Guest:Qi MingyangChairman of the Board of Directors of Golden State Holdings Limited ZongguishengChairman of Beijing Sandi Technology Co., Ltd. Han DaohuChairman of Lemobaba Dr. Gao WenzhongDirector of All-China Federation of M&A Associations, Executive President of CEC |
|
17:45 - 17:55 |
Host's Closing Remarks |
Scan the QR code to register now

3,Conference Partners
#Frost & Sullivan's New Investment Conference has launched a Weibo topic interaction. Welcome to participate! Come and discuss your top concerns about the life science industry and your expectations for the conference!


2025 Frost & Sullivan New Investment Conference & Weibo Health
Collect stamps and check in activities
[Event Time] August 27-28, 2025
[Event Introduction]
1. Guests attending the event can collect the 'Check-in Handbook' at the 'Weibo Health' booth;
2. Bring the 'Check-in Handbook' to the designated check-in point at the venue (with Weibo health logo), take a photo, check in, and stamp it.
3. After completing all stamping actions at the check-in points, return to the Weibo Health booth and post a Weibo post with the topic #Frost & Sullivan New Investment Conference# and a selfie photo;
4. Receive a "Conference Exclusive Gift" at the Weibo Health booth by presenting your stamped manual and Weibo post.
4,Review of Previous Sessions
The New Investment Event (NIE) originated from the Frost & Sullivan Growth, Innovation and Leadership Summit, which was established by Frost & Sullivan (Frost & Sullivan, abbreviated as: Frost & Sullivan).
The Frost & Sullivan Summit is held globally in over 20 countries and regions, with a history of nearly 30 years. It has attracted the deep participation of a large number of Fortune Global 1,000 companies, top domestic and international financial institutions, and other leading enterprises. It helps them identify opportunities, innovate continuously, accelerate growth, and gain a leadership position in an increasingly complex and changing world.
The Frost & Sullivan Summit was launched in China in 2008 with the purpose of 'based in Shanghai, serving the whole country, facing the world, and achieving win-win cooperation'. By 2025, it has held its nineteenth session, with a cumulative participation of over 15,000 professional visitors.
Today, the Frost & Sullivan Summit has become an important platform for outstanding domestic enterprises, the investment community, and regulatory authorities to exchange successful experiences and jointly explore development directions. It is also a vital window through which the world understands China's most cutting-edge development trends.

🔗 2024 Annual Highlights —— Third Frost & Sullivan New Investment Conference

🔗 2023 Frost & Sullivan Annual Review —— Frost & Sullivan's New Investment Conference

5,Sign up for the conference
August 27 - 28, 2025
The 19th Frost & Sullivan China Growth, Innovation and Leadership Summit 2023 and the 4th New Investment Conference
Looking forward to meeting with you
Scan the QR codeorClick on the end of the article to read the original text.
Sign up now

6Conference Support and Sponsorship Consulting
If you are interested in learning more about the cooperation and sponsorship details of this conference, please contact us:
General Assembly Consultation Hotline:021-3209-6800, then dial 8672
Conference consultation email:GIL@frostchina.com

